breast neoplasms
Showing NaN - NaN of 44
Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))
Completed
- Breast Neoplasms
- KU-0059436 (AZD2281) (PARP inhibitor)
-
West Hollywood, California
- +16 more
Jan 24, 2023
Breast Tumors Trial in Spain (No intervention)
Recruiting
- Breast Neoplasms
- No intervention
-
Elche, Alicante, Spain
- +39 more
Jan 20, 2023
Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,
Recruiting
- Breast Neoplasms
- +2 more
- Trastuzumab Deruxtecan
- +5 more
-
Springdale, Arkansas
- +203 more
Jan 13, 2023
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +141 more
Nov 15, 2022
Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)
Completed
- Breast Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Yuma, Arizona
- +93 more
Nov 4, 2022
Breast Tumors, Tumor Metastasis Trial in Worldwide (Imlunestrant, Exemestane, Fulvestrant)
Recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- Imlunestrant
- +3 more
-
Chandler, Arizona
- +238 more
Aug 17, 2022
Breast Tumors Trial in Worldwide (pembrolizumab, paclitaxel, nab-paclitaxel)
Recruiting
- Breast Neoplasms
- pembrolizumab
- +6 more
-
Tucson, Arizona
- +188 more
Aug 11, 2022
Ovarian Tumors, Breast Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Ovarian Neoplasms
- Breast Neoplasms
-
Tucson, Arizona
- +22 more
Jul 20, 2022
Quality of Life in Metastatic Breast Cancer Second Line
Completed
- Breast Neoplasms
-
Huelva, AndalucĂa, Spain
- +28 more
Jun 29, 2022
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)
Completed
- Breast Neoplasms
- +2 more
-
Flagstaff, Arizona
- +361 more
Dec 20, 2021
Breast Tumors Trial in Worldwide (Ipatasertib, Paclitaxel, Placebo)
Breast Tumors Trial in Spain, United States (Fulvestrant, Sapanisertib)
Completed
- Breast Neoplasms
-
Mobile, Alabama
- +52 more
Nov 20, 2020
Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Background hormonal therapy)
Terminated
- Breast Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +2 more
-
Bakersfield, California
- +70 more
Jul 29, 2020
Early Access To Pertuzumab And Trastuzumab Emtansine
Completed
- Breast Neoplasms
-
Madrid, SpainPuerta de Hierro University Hospital
Mar 4, 2020
Breast Tumors Trial in Ireland, Spain (PD-0332991 (Palbociclib), Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991 (Palbociclib)
- +2 more
-
Cork, Ireland
- +31 more
Feb 3, 2020
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib)
Terminated
- Breast Neoplasms
- +2 more
-
Greenbrae, California
- +70 more
Oct 10, 2019